Five-year follow-up of a single-centre RCT in high-risk newborns: 8 weeks of twice-daily emollient vs routine skin care gave lower AD prevalence at 5 years (12.3% vs 24.0%; RR 0.52, 95% CI 0.26–1.02; p=.048; n=177), but not significant after multiple imputation.
RCTn = 177
Cremin et al. Five-year outcomes of the STOP-AD randomised controlled trial: Long-term effects of early emollient therapy in high-risk infants